Table 3.
Overview of EORTC QLQ C30 and CR29
| Category | Data |
|---|---|
| QLQ C30 (n = 17) | |
| Global health status | 82.8 ± 12.7 |
| Physical functioning | 92.2 ± 10.1 |
| Role functioning | 86.3 ± 17.9 |
| Emotional functioning | 88.7 ± 15.6 |
| Cognitive functioning | 94.1 ± 10.1 |
| Social functioning | 88.2 ± 14.1 |
| Fatigue | 15.0 ± 13.6 |
| Nausea and vomiting | 1.0 ± 4.0 |
| Pain | 9.8 ± 16.7 |
| Dyspnea | 0 |
| Insomnia | 19.6 ± 23.7 |
| Appetite loss | 1.9 ± 8.1 |
| Constipation | 15.7 ± 33.6 |
| Diarrhea | 9.8 ± 15.7 |
| Financial difficulties | 3.9 ± 11.1 |
| QLQ CR29 (n = 17) | |
| Body image | 10.5 ± 12.1 |
| Anxiety | 17.6 ± 17.1 |
| Weight loss | 19.6 ± 29.0 |
| Urinary frequency | 27.5 ± 26.9 |
| Blood and mucus in stool | 13.7 ± 23.7 |
| Dysuria | 2.0 ± 8.1 |
| Abdominal pain | 15.7 ± 31.4 |
| Buttock pain | 11.8 ± 20.2 |
| Bloating | 19.6 ± 31.3 |
| Dry mouth | 35.3 ± 83.7 |
| Hair loss | 0 |
| Taste | 3.9 ± 16.2 |
| Flatulencea | 41.7 ± 35.5 |
| Fecal incontinencea | 8.3 ± 14.9 |
| Sore skin around anusa | 10.4 ± 20.1 |
| Stool frequencya | 20.8 ± 17.7 |
| Embarrassmenta | 12.5 ± 16.7 |
| Sexual interest, men (n = 12) | 36.1 ± 22.3 |
| Impotence, men | 47.2 ± 43.7 |
| Sexual interest, women (n = 5) | 40.0 ± 43.5 |
| Dyspareunia, women (n = 4) | 16.7 ± 33.3 |
Values are presented as mean±standard deviation.
EORTC, European Organization for Research and Treatment of Cancer; C30, core questionnaire; CR29, 29-item module.
a
No stoma-related quality of life is presented in this table since only 2 patients reported on this.